Renye Yue

1.1k total citations · 2 hit papers
24 papers, 890 citations indexed

About

Renye Yue is a scholar working on Biomedical Engineering, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Renye Yue has authored 24 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomedical Engineering, 9 papers in Materials Chemistry and 8 papers in Molecular Biology. Recurrent topics in Renye Yue's work include Nanoplatforms for cancer theranostics (15 papers), Advanced Nanomaterials in Catalysis (6 papers) and Ferroptosis and cancer prognosis (5 papers). Renye Yue is often cited by papers focused on Nanoplatforms for cancer theranostics (15 papers), Advanced Nanomaterials in Catalysis (6 papers) and Ferroptosis and cancer prognosis (5 papers). Renye Yue collaborates with scholars based in China, South Korea and Hong Kong. Renye Yue's co-authors include Guosheng Song, Guoqiang Guan, Xiaobing Zhang, Youjuan Wang, Cheng Zhang, Zhe Dong, Lingling Lei, Nan Ma, Huiyi Liu and Baoli Yin and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Renye Yue

23 papers receiving 886 citations

Hit Papers

Enhancing Fractionated Cancer Therapy: A Triple-Anthracen... 2024 2026 2025 2024 2025 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renye Yue China 17 566 355 317 221 164 24 890
Baozhong Shen China 14 585 1.0× 571 1.6× 254 0.8× 161 0.7× 257 1.6× 24 1.3k
Jiefu Jin United States 14 511 0.9× 344 1.0× 244 0.8× 230 1.0× 130 0.8× 21 880
Renfa Liu China 16 546 1.0× 284 0.8× 201 0.6× 158 0.7× 127 0.8× 32 823
Jingyi Zhu China 10 530 0.9× 294 0.8× 203 0.6× 167 0.8× 189 1.2× 26 756
Zhongling Wang China 17 681 1.2× 334 0.9× 284 0.9× 500 2.3× 99 0.6× 41 1.1k
Danli Sheng China 12 833 1.5× 252 0.7× 236 0.7× 264 1.2× 219 1.3× 24 1.0k
Yikai Xu China 14 527 0.9× 263 0.7× 269 0.8× 161 0.7× 221 1.3× 24 804
Xujiang Yu China 17 1.1k 1.9× 765 2.2× 281 0.9× 343 1.6× 242 1.5× 24 1.6k
Avinash Srivatsan United States 14 472 0.8× 280 0.8× 414 1.3× 165 0.7× 228 1.4× 18 929

Countries citing papers authored by Renye Yue

Since Specialization
Citations

This map shows the geographic impact of Renye Yue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renye Yue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renye Yue more than expected).

Fields of papers citing papers by Renye Yue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renye Yue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renye Yue. The network helps show where Renye Yue may publish in the future.

Co-authorship network of co-authors of Renye Yue

This figure shows the co-authorship network connecting the top 25 collaborators of Renye Yue. A scholar is included among the top collaborators of Renye Yue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renye Yue. Renye Yue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Wei, Guoqiang Guan, Renye Yue, et al.. (2025). Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy. Chemical Reviews. 125(4). 1897–1961. 25 indexed citations breakdown →
2.
Du, Huan, Renye Yue, Yuzhen Yu, et al.. (2025). An Integrated Afterglow and MRI Probe for In Vivo Imaging of ATP in Tumor Metabolism. Advanced Functional Materials. 36(20).
3.
Yue, Renye, Zhe Li, Huiyi Liu, et al.. (2024). Imaging-guided companion diagnostics in radiotherapy by monitoring APE1 activity with afterglow and MRI imaging. Nature Communications. 15(1). 6349–6349. 24 indexed citations
4.
Yue, Renye, Huiyi Liu, Huan Du, et al.. (2024). Enzyme-activated nanomaterials for MR imaging and tumor therapy. Coordination Chemistry Reviews. 510. 215842–215842. 23 indexed citations
5.
Guan, Guoqiang, Huiyi Liu, Qingpeng Zhang, et al.. (2023). Ultrasmall PtMn nanoparticles as sensitive manganese release modulator for specificity cancer theranostics. Journal of Nanobiotechnology. 21(1). 434–434. 7 indexed citations
6.
Xu, Li, Renye Yue, Guoqiang Guan, et al.. (2023). Recent development of pH‐responsive theranostic nanoplatforms for magnetic resonance imaging‐guided cancer therapy. SHILAP Revista de lepidopterología. 3(3). 20220002–20220002. 74 indexed citations
7.
Chen, Baode, Renye Yue, Zhe Dong, et al.. (2023). Stimuli-responsive switchable MRI nanoprobe for tumor theranostics. Nano Today. 51. 101931–101931. 36 indexed citations
8.
Xu, Li, Chang Lu, Huiyi Liu, et al.. (2023). Dynamic–Reversible MRI Nanoprobe for Continuous Imaging Redox Homeostasis in Hepatic Ischemia–Reperfusion Injury. ACS Nano. 17(10). 9529–9542. 42 indexed citations
10.
Yue, Renye, Ziqi Zhou, Xu Li, et al.. (2023). GSH/APE1 Cascade-Activated Nanoplatform for Imaging Therapy Resistance Dynamics and Enzyme-Mediated Adaptive Ferroptosis. ACS Nano. 17(14). 13792–13810. 43 indexed citations
11.
Lei, Lingling, Fengrui Yang, Li Xu, et al.. (2023). Zinc–Carnosine Metallodrug Network as Dual Metabolism Inhibitor Overcoming Metabolic Reprogramming for Efficient Cancer Therapy. Nano Letters. 23(7). 2659–2668. 43 indexed citations
12.
Guan, Guoqiang, Cheng Zhang, Huiyi Liu, et al.. (2022). Ternary Alloy PtWMn as a Mn Nanoreservoir for High‐Field MRI Monitoring and Highly Selective Ferroptosis Therapy. Angewandte Chemie. 134(31). 16 indexed citations
13.
Lei, Lingling, Zhe Dong, Xu Li, et al.. (2022). Metal-fluorouracil networks with disruption of mitochondrion enhanced ferroptosis for synergistic immune activation. Theranostics. 12(14). 6207–6222. 41 indexed citations
14.
Dong, Zhe, Liang Peng, Guoqiang Guan, et al.. (2022). Overcoming Hypoxia‐Induced Ferroptosis Resistance via a19F/1H‐MRI Traceable Core‐Shell Nanostructure. Angewandte Chemie. 134(48). 7 indexed citations
15.
Dong, Zhe, Liang Peng, Guoqiang Guan, et al.. (2022). Overcoming Hypoxia‐Induced Ferroptosis Resistance via a19F/1H‐MRI Traceable Core‐Shell Nanostructure. Angewandte Chemie International Edition. 61(48). e202206074–e202206074. 82 indexed citations
16.
Guan, Guoqiang, Cheng Zhang, Huiyi Liu, et al.. (2022). Ternary Alloy PtWMn as a Mn Nanoreservoir for High‐Field MRI Monitoring and Highly Selective Ferroptosis Therapy. Angewandte Chemie International Edition. 61(31). e202117229–e202117229. 89 indexed citations
17.
Yue, Renye, Mi Chen, & Nan Ma. (2020). Dual MicroRNA-Triggered Drug Release System for Combined Chemotherapy and Gene Therapy with Logic Operation. ACS Applied Materials & Interfaces. 12(29). 32493–32502. 48 indexed citations
18.
Yue, Renye, Zhi Li, Ganglin Wang, Junying Li, & Nan Ma. (2018). Logic Sensing of MicroRNA in Living Cells Using DNA-Programmed Nanoparticle Network with High Signal Gain. ACS Sensors. 4(1). 250–256. 34 indexed citations
19.
Wang, Ganglin, et al.. (2018). DNA-templated nanoparticle complexes for photothermal imaging and labeling of cancer cells. Nanoscale. 10(35). 16508–16520. 24 indexed citations
20.
Li, Zhi, Ganglin Wang, Xuewen He, et al.. (2017). MicroRNA-Catalyzed Cancer Therapeutics Based on DNA-Programmed Nanoparticle Complex. ACS Applied Materials & Interfaces. 9(39). 33624–33631. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026